世界の寄生虫病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Parasitic Diseases Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5930
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、寄生虫病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペプチド薬、防虫剤、殺ダニ剤、その他）、用途別市場規模（商業用、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・寄生虫病治療の市場動向
・企業の競争状況、市場シェア
・寄生虫病治療の種類別市場規模と予測2016-2027（ペプチド薬、防虫剤、殺ダニ剤、その他）
・寄生虫病治療の用途別市場規模と予測2016-2027（商業用、家庭用）
・寄生虫病治療の北米市場規模2016-2027（アメリカ、カナダ）
・寄生虫病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・寄生虫病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・寄生虫病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・寄生虫病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer、F. Hoffmann-La Roche、GlaxoSmithKline、Pfizer、Sanaria）
・結論

Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.

Market Analysis and Insights: Global Parasitic Diseases Therapeutic Market
The global Parasitic Diseases Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parasitic Diseases Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parasitic Diseases Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parasitic Diseases Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parasitic Diseases Therapeutic market.

Global Parasitic Diseases Therapeutic Scope and Market Size
Parasitic Diseases Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parasitic Diseases Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Peptides Medicine
Insect Repellent
Acaricide
Other

Segment by Application
Commercial
Household

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parasitic Diseases Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Peptides Medicine
1.2.3 Insect Repellent
1.2.4 Acaricide
1.2.5 Other
1.3 Market by Application
1.3.1 Global Parasitic Diseases Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Commercial
1.3.3 Household
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Parasitic Diseases Therapeutic Market Perspective (2016-2027)
2.2 Parasitic Diseases Therapeutic Growth Trends by Regions
2.2.1 Parasitic Diseases Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parasitic Diseases Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Parasitic Diseases Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Parasitic Diseases Therapeutic Industry Dynamic
2.3.1 Parasitic Diseases Therapeutic Market Trends
2.3.2 Parasitic Diseases Therapeutic Market Drivers
2.3.3 Parasitic Diseases Therapeutic Market Challenges
2.3.4 Parasitic Diseases Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Parasitic Diseases Therapeutic Players by Revenue
3.1.1 Global Top Parasitic Diseases Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Parasitic Diseases Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Parasitic Diseases Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parasitic Diseases Therapeutic Revenue
3.4 Global Parasitic Diseases Therapeutic Market Concentration Ratio
3.4.1 Global Parasitic Diseases Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parasitic Diseases Therapeutic Revenue in 2020
3.5 Parasitic Diseases Therapeutic Key Players Head office and Area Served
3.6 Key Players Parasitic Diseases Therapeutic Product Solution and Service
3.7 Date of Enter into Parasitic Diseases Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Parasitic Diseases Therapeutic Breakdown Data by Type
4.1 Global Parasitic Diseases Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2022-2027)

5 Parasitic Diseases Therapeutic Breakdown Data by Application
5.1 Global Parasitic Diseases Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Parasitic Diseases Therapeutic Market Size (2016-2027)
6.2 North America Parasitic Diseases Therapeutic Market Size by Type
6.2.1 North America Parasitic Diseases Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Parasitic Diseases Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Parasitic Diseases Therapeutic Market Size by Type (2016-2027)
6.3 North America Parasitic Diseases Therapeutic Market Size by Application
6.3.1 North America Parasitic Diseases Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Parasitic Diseases Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Parasitic Diseases Therapeutic Market Size by Application (2016-2027)
6.4 North America Parasitic Diseases Therapeutic Market Size by Country
6.4.1 North America Parasitic Diseases Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Parasitic Diseases Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Parasitic Diseases Therapeutic Market Size (2016-2027)
7.2 Europe Parasitic Diseases Therapeutic Market Size by Type
7.2.1 Europe Parasitic Diseases Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Parasitic Diseases Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Parasitic Diseases Therapeutic Market Size by Type (2016-2027)
7.3 Europe Parasitic Diseases Therapeutic Market Size by Application
7.3.1 Europe Parasitic Diseases Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Parasitic Diseases Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Parasitic Diseases Therapeutic Market Size by Application (2016-2027)
7.4 Europe Parasitic Diseases Therapeutic Market Size by Country
7.4.1 Europe Parasitic Diseases Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Parasitic Diseases Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Type
8.2.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Application
8.3.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region
8.4.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Parasitic Diseases Therapeutic Market Size (2016-2027)
9.2 Latin America Parasitic Diseases Therapeutic Market Size by Type
9.2.1 Latin America Parasitic Diseases Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Parasitic Diseases Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Parasitic Diseases Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Parasitic Diseases Therapeutic Market Size by Application
9.3.1 Latin America Parasitic Diseases Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Parasitic Diseases Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Parasitic Diseases Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Parasitic Diseases Therapeutic Market Size by Country
9.4.1 Latin America Parasitic Diseases Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Parasitic Diseases Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type
10.2.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application
10.3.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country
10.4.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Parasitic Diseases Therapeutic Introduction
11.1.4 Bayer Revenue in Parasitic Diseases Therapeutic Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Parasitic Diseases Therapeutic Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Introduction
11.3.4 GlaxoSmithKline Revenue in Parasitic Diseases Therapeutic Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Parasitic Diseases Therapeutic Introduction
11.4.4 Pfizer Revenue in Parasitic Diseases Therapeutic Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanaria
11.5.1 Sanaria Company Details
11.5.2 Sanaria Business Overview
11.5.3 Sanaria Parasitic Diseases Therapeutic Introduction
11.5.4 Sanaria Revenue in Parasitic Diseases Therapeutic Business (2016-2021)
11.5.5 Sanaria Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Parasitic Diseases Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Peptides Medicine
Table 3. Key Players of Insect Repellent
Table 4. Key Players of Acaricide
Table 5. Key Players of Other
Table 6. Global Parasitic Diseases Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Parasitic Diseases Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Parasitic Diseases Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Parasitic Diseases Therapeutic Market Share by Regions (2016-2021)
Table 10. Global Parasitic Diseases Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Parasitic Diseases Therapeutic Market Share by Regions (2022-2027)
Table 12. Parasitic Diseases Therapeutic Market Trends
Table 13. Parasitic Diseases Therapeutic Market Drivers
Table 14. Parasitic Diseases Therapeutic Market Challenges
Table 15. Parasitic Diseases Therapeutic Market Restraints
Table 16. Global Parasitic Diseases Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Parasitic Diseases Therapeutic Market Share by Players (2016-2021)
Table 18. Global Top Parasitic Diseases Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parasitic Diseases Therapeutic as of 2020)
Table 19. Ranking of Global Top Parasitic Diseases Therapeutic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Parasitic Diseases Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Parasitic Diseases Therapeutic Product Solution and Service
Table 23. Date of Enter into Parasitic Diseases Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parasitic Diseases Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2016-2021)
Table 27. Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Parasitic Diseases Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2016-2021)
Table 31. Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Parasitic Diseases Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Parasitic Diseases Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Parasitic Diseases Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Parasitic Diseases Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Parasitic Diseases Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Parasitic Diseases Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Parasitic Diseases Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Parasitic Diseases Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Parasitic Diseases Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Parasitic Diseases Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Parasitic Diseases Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Parasitic Diseases Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Parasitic Diseases Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Parasitic Diseases Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Parasitic Diseases Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Parasitic Diseases Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Parasitic Diseases Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Parasitic Diseases Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Parasitic Diseases Therapeutic Product
Table 66. Bayer Revenue in Parasitic Diseases Therapeutic Business (2016-2021) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. F. Hoffmann-La Roche Company Details
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product
Table 71. F. Hoffmann-La Roche Revenue in Parasitic Diseases Therapeutic Business (2016-2021) & (US$ Million)
Table 72. F. Hoffmann-La Roche Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Parasitic Diseases Therapeutic Product
Table 76. GlaxoSmithKline Revenue in Parasitic Diseases Therapeutic Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Parasitic Diseases Therapeutic Product
Table 81. Pfizer Revenue in Parasitic Diseases Therapeutic Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Sanaria Company Details
Table 84. Sanaria Business Overview
Table 85. Sanaria Parasitic Diseases Therapeutic Product
Table 86. Sanaria Revenue in Parasitic Diseases Therapeutic Business (2016-2021) & (US$ Million)
Table 87. Sanaria Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parasitic Diseases Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Peptides Medicine Features
Figure 3. Insect Repellent Features
Figure 4. Acaricide Features
Figure 5. Other Features
Figure 6. Global Parasitic Diseases Therapeutic Market Share by Application: 2020 VS 2027
Figure 7. Commercial Case Studies
Figure 8. Household Case Studies
Figure 9. Parasitic Diseases Therapeutic Report Years Considered
Figure 10. Global Parasitic Diseases Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Parasitic Diseases Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Parasitic Diseases Therapeutic Market Share by Regions: 2020 VS 2027
Figure 13. Global Parasitic Diseases Therapeutic Market Share by Regions (2022-2027)
Figure 14. Global Parasitic Diseases Therapeutic Market Share by Players in 2020
Figure 15. Global Top Parasitic Diseases Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parasitic Diseases Therapeutic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Parasitic Diseases Therapeutic Revenue in 2020
Figure 17. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2016-2021)
Figure 18. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2022-2027)
Figure 19. North America Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Parasitic Diseases Therapeutic Market Share by Type (2016-2027)
Figure 21. North America Parasitic Diseases Therapeutic Market Share by Application (2016-2027)
Figure 22. North America Parasitic Diseases Therapeutic Market Share by Country (2016-2027)
Figure 23. United States Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Parasitic Diseases Therapeutic Market Share by Type (2016-2027)
Figure 27. Europe Parasitic Diseases Therapeutic Market Share by Application (2016-2027)
Figure 28. Europe Parasitic Diseases Therapeutic Market Share by Country (2016-2027)
Figure 29. Germany Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Parasitic Diseases Therapeutic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Parasitic Diseases Therapeutic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Parasitic Diseases Therapeutic Market Share by Region (2016-2027)
Figure 39. China Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Parasitic Diseases Therapeutic Market Share by Type (2016-2027)
Figure 47. Latin America Parasitic Diseases Therapeutic Market Share by Application (2016-2027)
Figure 48. Latin America Parasitic Diseases Therapeutic Market Share by Country (2016-2027)
Figure 49. Mexico Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Parasitic Diseases Therapeutic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Parasitic Diseases Therapeutic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Parasitic Diseases Therapeutic Market Share by Country (2016-2027)
Figure 55. Turkey Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Parasitic Diseases Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2016-2021)
Figure 62. Sanaria Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の寄生虫感染症検査市場規模・現状・予測（2021年-2027年）

Global Parasitic Infection Testing Market Size, Status and Forecast 2021-2027
QFJ1-4656 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、寄生虫感染症検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（顕微鏡検査、血清学的検査、分子ベースアッセイ、プロテオミクス検査）、用途別市場規模（病院、クリニック、診断研究所、その他）、主要地域別市...

世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Lymphoblastic Lymphoma Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5837 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、リンパ芽球性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞移植、標的療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のアフェレシス療法市場規模・現状・予測（2021年-2027年）

Global Therapeutic Apheresis Market Size, Status and Forecast 2021-2027
QFJ1-4950 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、アフェレシス療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療用血漿交換、赤血球交換）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のマゴットセラピー市場規模・現状・予測（2021年-2027年）

Global Maggot Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4454 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、マゴットセラピーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬品、薬用包帯、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5351 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌシネルセン、オナセムノゲンアベパルボベック）、用途別市場規模（タイプ1SMA、タイプ2 SMA、その他）、主要地域別市場規...

世界の外分泌膵機能不全治療市場規模・現状・予測（2021年-2027年）

Global Exocrine Pancreatic Insufficiency Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5732 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、外分泌膵機能不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（膵酵素補充療法、栄養療法）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-3943 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の微生物治療製品市場規模・現状・予測（2021年-2027年）

Global Microbial Therapeutic Products Market Size, Status and Forecast 2021-2027
QFJ1-4502 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、微生物治療製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バクテリア、菌類、その他）、用途別市場規模（病院、製薬・バイオ医薬品企業、研究・学術機関）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のサルコペニア治療市場規模・現状・予測（2021年-2027年）

Global Sarcopenia Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-6002 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、サルコペニア治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロテインサプリメント、カルシウムサプリメント、その他）、用途別市場規模（オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ...

世界の副鼻腔治療薬市場規模・現状・予測（2021年-2027年）

Global Sinus Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4863 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、副鼻腔治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の寄生虫感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parasitic Infection Testing Market The global Parasitic Infection Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
世界のアフェレシス療法市場規模・現状・予測（2021年-2027年） Therapeutic apheresis is a procedure of the removal of a blood component from a patient using the apheresis technology. Therapeutic apheresis is used for the purpose of removing defective cells. Therapeutic apheresis is also used for the treatment of conditions in which a component or a pathogenic s…
世界のマゴットセラピー市場規模・現状・予測（2021年-2027年） Maggot therapy is a type of biotherapy involving the introduction of live, disinfected maggots (fly larvae) into the non-healing skin and soft tissue wound(s) of a human or animal for the purpose of cleaning out the necrotic (dead) tissue within a wound (debridement) and disinfection. North America …
世界の院内感染治療市場規模・現状・予測（2021年-2027年） A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infectio…